1985 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the expert's scholarly documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Placebos Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
irinotecan Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1985 2019

Acute aerobic exercise effects on cognitive function in breast cancer survivors: A randomized crossover trial

Salerno, E. A., Rowland, K. M., Kramer, A. F. & McAuley, E., Apr 23 2019, In : BMC Cancer. 19, 1, 371.

Research output: Contribution to journalArticle

Open Access
Cross-Over Studies
Cognition
Survivors
Exercise
Breast Neoplasms

Androgen Mediation—and Antiandrogens Mitigation—of the Epidermal Growth Factor Receptor (EGFR) Inhibitor–Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series

Le-Rademacher, J. G., Rowland, K. M., Atherton, P. J., Dakhil, C., Sun, Z., Tan, A., Schmidt, L., Nguyen, P. L., Radecki Breitkopf, C., Pittelkow, M., Tindall, D., Menon, S. & Jatoi, A., Jun 1 2019, In : American Journal of Hospice and Palliative Medicine. 36, 6, p. 519-525 7 p.

Research output: Contribution to journalArticle

Androgen Antagonists
Exanthema
Epidermal Growth Factor Receptor
Androgens
Spironolactone

Phase II trial of eribulin in patients with metastatic hormone refractory prostate cancer: A trial of the ECOG-ACRIN Cancer Research Group (E5805)

Stein, M. N., Chen, Y. H., Carducci, M. A., Hudes, G. R., Lerma, P. M., Tan, W. W., Dalune, R., Rowland, K. M., Kuzel, T. M. & DiPaola, R. S., Apr 1 2019, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 42, 4, p. 375-381 7 p.

Research output: Contribution to journalArticle

eribulin
Prostatic Neoplasms
Hormones
Drug Therapy
Research
Carboplatin
Paclitaxel
Ovarian Neoplasms
Placebos
Disease-Free Survival

A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): An Alliance trial

Jatoi, A., Steen, P. D., Atherton, P. J., Moore, D. F., Rowland, K. M., Le-Lindqwister, N. A., Adonizio, C. S., Jaslowski, A. J., Sloan, J. & Loprinzi, C., Aug 1 2017, In : Annals of Oncology. 28, 8, p. 1957-1963 7 p., mdx232.

Research output: Contribution to journalArticle

Creatine
Anorexia
Weight Loss
Randomized Controlled Trials
Placebos